NCT03229967View on ClinicalTrials.gov

Gastrointestinal Microbiome Influence on the Development of Bronchopulmonary Dysplasia

CompletedOBSERVATIONAL
Enrollment

197

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Bronchopulmonary Dysplasia
Interventions
DIAGNOSTIC_TEST

16S rRNA stool microbiome sequencing.

This is an observational cohort that will undergo gut microbiome sequencing.

Trial Locations (2)

38105

LeBonheur Children's Hospital, Memphis

Regional One Health, Memphis

All Listed Sponsors
lead

University of Tennessee

OTHER

NCT03229967 - Gastrointestinal Microbiome Influence on the Development of Bronchopulmonary Dysplasia | Biotech Hunter | Biotech Hunter